SC
NVO

Solstein Capital’s Novo Nordisk NVO Stock Holding History

Solstein Capital’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$29.2K Hold
794
– – 0.01% 264
2025
Q4 		$40.4K Hold
794
– – 0.02% 226
2025
Q3 		$44.1K Sell
794
-14,483
-95% -$848K 0.01% 213
2025
Q2 		$1.05M Hold
15,277
– – 0.54% 45
2025
Q1 		$1.06M Sell
15,277
-5,560
-27% -$459K 0.62% 40
2024
Q4 		$1.79M Sell
20,837
-5,000
-19% -$541K 1% 23
2024
Q3 		$3.08M Sell
25,837
-5,000
-16% -$667K 1.63% 13
2024
Q2 		$4.4M Hold
30,837
– – 2.87% 6
2024
Q1 		$3.96M Sell
30,837
-921
-3% -$110K 2.75% 7
2023
Q4 		$3.29M Buy
31,758
+28
+0.1% +$2.77K 2.43% 9
2023
Q3 		$2.89M Hold
31,730
– – 2.48% 9
2023
Q2 		$2.57M Buy
31,730
+380
+1% +$31K 2.14% 12
2023
Q1 		$2.49M Sell
31,350
-2,290
-7% -$162K 2.17% 13
2022
Q4 		$2.28M Sell
33,640
-3,528
-9% -$207K 1.9% 13
2022
Q3 		$1.85M Buy
37,168
+288
+0.8% +$15.4K 1.63% 14
2022
Q2 		$2.06M Buy
36,880
+386
+1% +$21.4K 1.57% 13
2022
Q1 		$2.03M Sell
36,494
-1,088
-3% -$55.8K 1.33% 19
2021
Q4 		$2.1M Sell
37,582
-782
-2% -$42.4K 1.27% 18
2021
Q3 		$1.84M Buy
38,364
+25,520
+199% +$1.23M 1.06% 23
2021
Q2 		$538K Sell
12,844
-90
-0.7% -$3.49K 0.66% 45
2021
Q1 		$436K Buy
12,934
+2,760
+27% +$98.3K 0.59% 55
2020
Q4 		$356 Buy
10,174
+1,054
+12% +$36.4K 0.15% 56
2020
Q3 		$317K Sell
9,120
-1,800
-16% -$60K 0.71% 41
2020
Q2 		$358K Buy
+10,920
New +$348K 0.85% 35

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Solstein Capital's NVO Position: Q1 2026 in Review

Solstein Capital held its Novo Nordisk (NVO) position steady in Q1 2026 at 794 shares worth $29.2K. The position accounts for 0.01% of the portfolio, ranked #264.

Solstein Capital first reported a position in NVO in Q2 2020 and has held it in 24 quarters since. The position peaked at $4.4M in Q2 2024. 1,272 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • Solstein Capital held 794 shares of Novo Nordisk worth $29.2K as of Q1 2026.
  • Solstein Capital left its Novo Nordisk share count unchanged in Q1 2026.
  • Novo Nordisk made up 0.01% of Solstein Capital's portfolio in Q1 2026, its #264 holding.
  • Solstein Capital first reported a position in Novo Nordisk in Q2 2020 and has held it in 24 quarters since.
  • Solstein Capital's Novo Nordisk position peaked at $4.4M in Q2 2024.
  • 1,272 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Solstein Capital's 13F filing for Q1 2026, filed 14 May 2026.